Systemically administered PEDF against primary and secondary tumours in a clinically relevant osteosarcoma model

QR Code

Systemically administered PEDF against primary and secondary tumours in a clinically relevant osteosarcoma model

Background: Pigment epithelium-derived factor (PEDF) is an endogenous glycoprotein with a potential role as a therapeutic for osteosarcoma. Animal studies have demonstrated the biological effects of PEDF on osteosarcoma; however, these results are difficult to extrapolate for human use due to the ch...

Full description

Bibliographic Details
Main Authors:	Broadhead, M., Dass, Crispin, Choong, P.
Format:	Journal Article
Published:	Nature Publishing Group 2011
Online Access:	http://hdl.handle.net/20.500.11937/19073

Similar Items

Efficacy of Continuously Administered PEDF-Derived Synthetic Peptides against Osteosarcoma Growth and Metastasis
by: Broadhead, M., et al.
Published: (2012)

The applied biochemistry of PEDF and implications for tissue homeostasis
by: Broadhead, M., et al.
Published: (2010)

Cell and Molecular Biology Underpinning the Effects of PEDF on Cancers in General and Osteosarcoma in Particular
by: Chandolu, V., et al.
Published: (2012)

Making gene therapy for osteosarcoma a reality
by: Broadhead, M., et al.
Published: (2010)

Doxorubicin action on mitochondria: relevance to osteosarcoma therapy?
by: Armstrong, J., et al.
Published: (2015)

The Molecular Pathogenesis of Osteosarcoma: A Review
by: Choong, P., et al.
Published: (2011)

Alginate bead-encapsulated PEDF induces ectopic bone formation in vivo in the absence of co-administered mesenchymal stem cells.
by: Elahy, M., et al.
Published: (2015)

The Emerging Role of PEDF in Stem Cell Biology
by: Elahy, Mina, et al.
Published: (2012)

Anti-chondrosarcoma effects of PEDF mediated via molecules important to apoptosis, cell cycling, adhesion and invasion
by: Tan, M., et al.
Published: (2010)

Potential of pigment epithelium-derived factor (PEDF) as a bone regenerative biopharmaceutical
by: Lee, P., et al.
Published: (2016)

RECK in Osteosarcoma: A Novel Role in Tumour Vasculature and Inhibition of Tumorigenesis in an Orthotopic Mode
by: Clark, J., et al.
Published: (2011)

PEDF-induced alteration of metabolism leading to insulin resistance
by: Carnagarin, Revathy, et al.
Published: (2015)

Mechanisms of PEDF-mediated protection against reactive oxygen species damage in diabetic retinopathy and neuropathy
by: Elahy, M., et al.
Published: (2014)

Canine osteosarcoma: a relevant comparative model for osteosarcoma in man
by: Selvarajah, Gayathri Thevi
Published: (2011)

New clinically relevant, orthotopic mouse models of human chondrosarcoma with spontaneous metastasis
by: Clark, J., et al.
Published: (2010)

PEDF attenuates insulin-dependent molecular pathways of glucose homeostasis in skeletal myocytes
by: Carnagarin, R., et al.
Published: (2015)

Regulation of MT1-MMP and MMP-2 by the Serpin PEDF: A promising new target for metastatic cancer
by: Alcantara, M., et al.
Published: (2013)

RANK-Fc inhibits malignancy via inhibiting ERK activation and evoking caspase-3-mediated anoikis in human osteosarcoma cells
by: Akiyama, T., et al.
Published: (2010)

Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model
by: Tan, M., et al.
Published: (2013)

Insulin antagonises pigment epithelium-derived factor (PEDF)-induced modulation of lineage commitment of myocytes and heterotrophic ossification
by: Carnagarin, R., et al.
Published: (2018)

Anti-Tumour Effect of a Chitosan Delivery System for Doxorubicin
by: Tan, M., et al.
Published: (2010)

Doxorubicin-induced death in tumour cells and cardiomyocytes: is autophagy the key to improving future clinical outcomes?
by: Tacar, O., et al.
Published: (2013)

A nanoparticulate system that enhances the efficacy of the tumoricide Dz13 when administered proximal to the lesion site
by: Tan, M., et al.
Published: (2010)

Primary aggressive osteosarcoma of sphenoid bone
by: Che Jalil, Nur Asyilla, et al.
Published: (2023)

Primary aggressive osteosarcoma of sphenoid bone
by: Che Jalil, Nur Asyilla, et al.
Published: (2022)

The Effect of Krill Oil and n-3 Polyunsaturated Fatty Acids on Human Osteosarcoma Cell Proliferation and Migration.
by: Xiao, S., et al.
Published: (2015)

Direct anti-metastatic efficacy by the DNA enzyme Dz13 and downregulated MMP-2, MMP-9 and MT1-MMP in tumours
by: Tan, M., et al.
Published: (2010)

Cardiomyocyte apoptosis vs autophagy with prolonged doxorubicin treatment: Comparison with osteosarcoma cells
by: Tacar, O., et al.
Published: (2015)

Dz13: c-Jun Downregulation and Tumour Cell Death
by: Elahy, M., et al.
Published: (2011)

Methods for co-culturing tumour and endothelial cells: systems and their applications
by: Moorst, M., et al.
Published: (2011)

Zoledronic acid: Pleiotropic anti-tumor mechanism and therapeutic outlook for osteosarcoma
by: Ouyang, Z., et al.
Published: (2018)

Role of Bcl-2 in tumour cell survival and implications for pharmacotherapy
by: Tomek, M., et al.
Published: (2012)

Primary pulmonary osteosarcoma in a dog with associated hypertrophic osteopathy
by: Seiler, R. J.
Published: (1979)

Role of vitamin D metabolism in cutaneous tumour formation and progression
by: Nemazannikova, N., et al.
Published: (2013)

Pigment Epithelium-Derived Factor as an Impending Therapeutic Agent Against Vascular Epithelial Growth Factor-Driven Tumor-Angiogenesis
by: Manalo, K., et al.
Published: (2011)

Reduction in tumour cell invasion by pigment epithelium-derived factor is mediated by membrane type-1 matrix metalloproteinase downregulation
by: Filiz, G., et al.
Published: (2012)

Pigment epithelium-derived factor upregulates collagen I and downregulates matrix metalloproteinase 2 in osteosarcoma cells, and colocalises to collagen I and heat shock protein 47 in fetal and adult bone
by: Alcantara, M., et al.
Published: (2014)

Heat shock protein expression analysis in canine osteosarcoma reveals HSP60 as a potentially relevant therapeutic target
by: Selvarajah, Gayathri Thevi, et al.
Published: (2013)

Finding chemo: the search for marine-based pharmaceutical drugs active against cancer
by: Indumathy, S., et al.
Published: (2013)

Combinatorial antimicrobial efficacy and mechanism of linalool against clinically-relevant Klebsiella pneumoniae
by: Yang, Shun Kai, et al.
Published: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3islnpl1uh316fud8uii5ns2u0